ACE2 and COVID-19: It has been indicated that ACE2 expression is stimulated by activation of the immune response [235], and early in SARS-CoV-2 research became clear that antagonizing ACE2 and/or TMPRSS2 could be of interest for COVID-19 therapies [191,236,237,238,239].